Sexual activity in implantable cardioverter defibrillator patients included in cardiac rehabilitation

被引:2
|
作者
Maria Maroto-Montero, Jose [1 ,2 ]
Maroto-de Pablo, Marta [2 ,3 ]
Starling-Duarte, Juan [1 ]
Prados-Cabiedas, Carolina [4 ]
Villahoz-Garcia, Carmen [2 ]
Cabrero-Soblechero, Lara [2 ]
Sanchez-Corbal, Marta [1 ]
Valverde-dos Anjos, Belen [1 ]
Munoz-Sanjuan, Yesica [1 ]
机构
[1] Hosp Vithas Nuestra Senora de Fatima, Unidad Rehabil Cardiaca, Vigo, Pontevedra, Spain
[2] Residencia Socio Sanitaria, Unidad Rehabil Cardiaca Ecoplar, Madrid, Spain
[3] Univ Autonoma, Fac Med, Madrid, Spain
[4] Hosp Univ Ramon & Cajal, Serv Cardiol, Unidad Rehabil Cardiaca, Madrid, Spain
来源
ARCHIVOS DE CARDIOLOGIA DE MEXICO | 2018年 / 88卷 / 02期
关键词
Implantable cardioverter defibrillator; Sexual activity; Cardiac rehabilitation; Spain;
D O I
10.1016/j.acmx.2017.07.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To analyse the effects of a Cardiac Rehabilitation Program (CRP) on quality of life and sexual activity levels in patients with implantable cardioverter defibrillators (ICD). Method: A total of 25 patients (22 men and 3 women) were included in a study that consisted of the analysis of any defibrillator discharges, their repercussion on the couple, and the effects of CRP on physical and psychological aspects, and on sexual activity (SA). Results: The mean age of the patients was 55 years (22 to 79). Initially, fear for device discharges was present in all patients. On arrival, 14 patients (56%) did not have any SA: 2 with ages of 69 and 79 years; one woman due to severe anxiety; an alcoholic man, and 10 because the ICD had been implanted less than 1 month before. Nine men and two women had restarted SA: 5 of them 5-52 months after the implantation, and the other 6, 30 days after implantation of the ICD while attending the CRP. At the end of the study, 21 patients had regained SA. Two men had clinical signs of depression and anxiety, with one requiring specialised treatment. Functional capacity improved significantly, 6.5 +/- 3.0 METs at the beginning of the program and 9.2 +/- 3.3 METs at the end, with a P < .005. There was only one inappropriate discharge. Conclusions: Discharges caused by newest devices have dropped significantly. This fact, together with the action of CRP at physical, psychological, and informative levels, makes it possible to control the dysfunctions in the quality of life and sexuality in patients. (C) 2017 Institute Nacional de Cardiologi'a Ignacio Chavez. Published by Masson Doyma Mexico S.A. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:116 / 123
页数:8
相关论文
共 50 条
  • [41] Update of implantable cardioverter/defibrillator and cardiac resynchronization therapy in heart failure
    Rami, T
    Shih, HT
    CURRENT OPINION IN CARDIOLOGY, 2004, 19 (03) : 264 - 269
  • [42] Implantable Cardioverter Defibrillator Prevents Sudden Cardiac Death in Systemic Sclerosis
    Bernardo, Pasquale
    Conforti, Maria Letizia
    Bellando-Randone, Silvia
    Pieragnoli, Paolo
    Blagojevic, Jelena
    Kaloudi, Olga
    Guiducci, Serena
    Porta, Francesco
    Padeletti, Luigi
    Gensini, Gian Franco
    Matucci-Cerinic, Marco
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (08) : 1617 - 1621
  • [43] Indications for Pacemakers, Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Devices
    Samii, Soraya M.
    MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (04) : 795 - +
  • [44] Development of indications for cardiac resynchronisation therapy in the implantable cardioverter defibrillator population
    Paisey, JR
    Yue, AM
    Moore, R
    Betts, TR
    Roberts, PR
    Morgan, JM
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 99 (02) : 187 - 190
  • [45] Depression and Implantable Cardioverter-Defibrillator Implantation in Black Patients at Risk for Sudden Cardiac Death
    Boursiquot, Brian C.
    Young, Rebecca
    Alhanti, Brooke
    Sullivan II, Lonnie T.
    Maul, Andrew J.
    Khedagi, Apurva
    Sears, Samuel F.
    Jackson II, Larry R.
    Thomas, Kevin L.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (14):
  • [46] Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator
    Arya, A
    Haghjoo, M
    Dehghani, MR
    Alasti, M
    Alizadeh, H
    Kazemi, B
    Sadr-Ameli, MA
    HEART RHYTHM, 2005, 2 (10) : 1094 - 1098
  • [47] Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator
    Klopotowski, Mariusz
    Kukula, Krzysztof
    Jamiolkowski, Jacek
    Oreziak, Artur
    Dabrowski, Maciej
    Chmielak, Zbigniew
    Witkowski, Adam
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
  • [48] Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator
    Pedersen, Susanne S.
    van den Broek, Krista C.
    Erdman, Ruud A. M.
    Jordaens, Luc
    Theuns, Dominic A. M. J.
    EUROPACE, 2010, 12 (10): : 1446 - 1452
  • [49] Cardiac transplantation in a patient with emotionally triggered implantable cardioverter defibrillator storms
    Chirine Parsai
    Robert F. Bonvini
    Bruno Schnetzler
    Henri Sunthorn
    Heart and Vessels, 2007, 22 : 349 - 351
  • [50] Assessment of Anxiety Level in Patients Receiving Implantable Cardioverter Defibrillator
    Mohammadi, Nooreddin
    Askari, Shahin
    Farahani, Mansooureh Ashghali
    Ghorbani, Azam
    Ghafarzadegan, Rezvan
    Masuomi, Nasrin
    CRESCENT JOURNAL OF MEDICAL AND BIOLOGICAL SCIENCES, 2019, 6 (01): : 13 - 17